—
C+
C+ The full Closelook — membership. Open the C+ overview

TELIX Pharmaceuticals Ltd (TLX.AU) — Quality & forensics

As of 2026-09-18 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

39 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

3.77 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

3/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-1.56 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.

Continue: the TLX.AU chart & overview

FAQ · from the current data · as of 2026-09-18

Quick answers

What is TELIX Pharmaceuticals Ltd's Closelook quality reading?

The composite reads 39/100 across 7 modules, as of 2026-09-18: valuation 17, quality 27, growth 48, balance sheet 32, cash quality 43, capital allocation 33, momentum 89. Closelook scores are research diary readings, not ratings or investment advice.

What is TELIX Pharmaceuticals Ltd's Altman Z-Score?

3.77, which sits in the safe zone (above 2.99) as of 2026-09-18. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is TELIX Pharmaceuticals Ltd's Piotroski F-Score?

3 of 9, as of 2026-09-18. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does TELIX Pharmaceuticals Ltd's Beneish M-Score indicate?

-1.56 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-09-18. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.